Masahiro Hirashiba

Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice

Ryou Fukushima, S. Kanamori, Masahiro Hirashiba et al. · Reproductive Toxicology · 2007 · 80 citations

Teratogenicity Study, Medicine, Dihydroorotate-dehydrogenase Inhibitor +6

Inhibiting the Teratogenicity of the Immunosuppressant Leflunomide in Mice by Supplementation of Exogenous Uridine

Ryou Fukushima, S. Kanamori, Masahiro Hirashiba et al. · Toxicological Sciences · 2009 · 32 citations · Full text

Inflammation, Immunosuppressant Leflunomide, Anti-inflammatory +13

Gestational Profiles of Rat Placental Lactogen-II(rPL-ll) and Growth Hormone(GH) im Maternal and Fetal Serum, Amniotic Fluid, and Placental Tissue.

Kurajiro Kishi, Masahiro Hirashiba, Yasuhiko Hasegawa · Endocrinologia Japonica · 1991 · 15 citations · Full text

Fertility, Fetal Medicine, Placental Tissue +19

Critical periods for the teratogenicity of immune‐suppressant Leflunomide in mice

Ryou Fukushima, S. Kanamori, Masahiro Hirashiba et al. · Congenital Anomalies · 2009 · 13 citations · Full text

Immunotoxicology, Immune Regulation, Immunology +18

Stimulation of rat placental lactogen-II (rPL-II) secretion by cultured trophoblasts by insulin: development of a rat placental cell culture system and effects of peptide hormones on rPL-II secretion <i>in vitro</i>

Kurajiro Kishi, Mitsuyasu Itoh, S. Kanamori et al. · Reproduction · 1993 · 12 citations